These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19075264)

  • 1. Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population.
    Johansen JS; Bojesen SE; Mylin AK; Frikke-Schmidt R; Price PA; Nordestgaard BG
    J Clin Oncol; 2009 Feb; 27(4):572-8. PubMed ID: 19075264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma YKL-40 and total and disease-specific mortality in the general population.
    Johansen JS; Bojesen SE; Tybjaerg-Hansen A; Mylin AK; Price PA; Nordestgaard BG
    Clin Chem; 2010 Oct; 56(10):1580-91. PubMed ID: 20798353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma YKL-40 levels and ischemic stroke in the general population.
    Kjaergaard AD; Bojesen SE; Johansen JS; Nordestgaard BG
    Ann Neurol; 2010 Nov; 68(5):672-80. PubMed ID: 21031582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observational and genetic plasma YKL-40 and cancer in 96,099 individuals from the general population.
    Kjaergaard AD; Nordestgaard BG; Johansen JS; Bojesen SE
    Int J Cancer; 2015 Dec; 137(11):2696-704. PubMed ID: 26095694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma YKL-40 levels in healthy subjects from the general population.
    Bojesen SE; Johansen JS; Nordestgaard BG
    Clin Chim Acta; 2011 Apr; 412(9-10):709-12. PubMed ID: 21272568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YKL-40 levels and atrial fibrillation in the general population.
    Marott SC; Benn M; Johansen JS; Jensen GB; Tybjærg-Hansen A; Nordestgaard BG
    Int J Cardiol; 2013 Aug; 167(4):1354-9. PubMed ID: 22525348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma YKL-40 predicts 10-year cardiovascular and all-cause mortality in individuals with type 2 diabetes.
    Lin CH; Li HY; Jiang YD; Chang TJ; Chuang LM
    Clin Endocrinol (Oxf); 2013 Aug; 79(2):185-91. PubMed ID: 22901243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum YKL-40 predicts relapse-free and overall survival in patients with American Joint Committee on Cancer stage I and II melanoma.
    Schmidt H; Johansen JS; Sjoegren P; Christensen IJ; Sorensen BS; Fode K; Larsen J; von der Maase H
    J Clin Oncol; 2006 Feb; 24(5):798-804. PubMed ID: 16391295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated plasma YKL-40, lipids and lipoproteins, and ischemic vascular disease in the general population.
    Kjaergaard AD; Johansen JS; Bojesen SE; Nordestgaard BG
    Stroke; 2015 Feb; 46(2):329-35. PubMed ID: 25624368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma YKL-40 levels are elevated in patients with chronic heart failure.
    Rathcke CN; Kistorp C; Raymond I; Hildebrandt P; Gustafsson F; Lip GY; Faber J; Vestergaard H
    Scand Cardiovasc J; 2010 Apr; 44(2):92-9. PubMed ID: 19961288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High serum concentration of YKL-40 is associated with short survival in patients with acute myeloid leukemia.
    Bergmann OJ; Johansen JS; Klausen TW; Mylin AK; Kristensen JS; Kjeldsen E; Johnsen HE
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8644-52. PubMed ID: 16361549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival.
    Johansen JS; Christensen IJ; Riisbro R; Greenall M; Han C; Price PA; Smith K; Brünner N; Harris AL
    Breast Cancer Res Treat; 2003 Jul; 80(1):15-21. PubMed ID: 12889595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma.
    Schmidt H; Johansen JS; Gehl J; Geertsen PF; Fode K; von der Maase H
    Cancer; 2006 Mar; 106(5):1130-9. PubMed ID: 16456816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inflammatory biomarker YKL-40 at admission is a strong predictor of overall mortality.
    Mygind ND; Iversen K; Køber L; Goetze JP; Nielsen H; Boesgaard S; Bay M; Johansen JS; Nielsen OW; Kirk V; Kastrup J
    J Intern Med; 2013 Feb; 273(2):205-16. PubMed ID: 23140269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival.
    Cintin C; Johansen JS; Christensen IJ; Price PA; Sørensen S; Nielsen HJ
    Cancer; 2002 Jul; 95(2):267-74. PubMed ID: 12124825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population.
    Rathcke CN; Raymond I; Kistorp C; Hildebrandt P; Faber J; Vestergaard H
    Int J Cardiol; 2010 Aug; 143(1):35-42. PubMed ID: 19223085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum YKL-40 predicts adverse clinical outcomes in patients with chronic heart failure.
    Bilim O; Takeishi Y; Kitahara T; Ishino M; Sasaki T; Suzuki S; Shishido T; Kubota I
    J Card Fail; 2010 Nov; 16(11):873-9. PubMed ID: 21055651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High serum YKL-40 level in patients with small cell lung cancer is related to early death.
    Johansen JS; Drivsholm L; Price PA; Christensen IJ
    Lung Cancer; 2004 Dec; 46(3):333-40. PubMed ID: 15541818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YKL-40 and alcoholic liver and pancreas damage and disease in 86,258 individuals from the general population: cohort and mendelian randomization studies.
    Kjaergaard AD; Bojesen SE; Nordestgaard BG; Johansen JS
    Clin Chem; 2014 Nov; 60(11):1429-40. PubMed ID: 25225167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival.
    Roslind A; Johansen JS; Christensen IJ; Kiss K; Balslev E; Nielsen DL; Bentzen J; Price PA; Andersen E
    Int J Cancer; 2008 Feb; 122(4):857-63. PubMed ID: 17957792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.